Jardine Matheson Holdings Limited (SGX:J36)
Singapore · Delayed Price · Currency is SGD · Price in USD | Market Cap | 20.76B -14.3% |
| Revenue (ttm) | 42.79B -7.1% |
| Net Income | 1.45B +1,023.0% |
| EPS | 4.90 +1,004.2% |
| Shares Out | 293.26M |
| PE Ratio | 14.61 |
| Forward PE | 9.83 |
| Dividend | 2.99 (4.20%) |
| Ex-Dividend Date | Aug 20, 2026 |
| Volume | 292,170 |
| Open | 56.30 |
| Previous Close | 55.36 |
| Day's Range | 55.16 - 56.95 |
| 52-Week Range | 52.85 - 82.50 |
| Beta | 0.46 |
| Analysts | Strong Buy |
| Price Target | 85.12 (+52.87%) |
| Est. Earnings | Oct 30, 2026 |
About Jardine Matheson Holdings
Jardine Matheson Holdings Limited operates in motor vehicles and related operations, property investment and development, health and beauty, home furnishings, engineering and construction, and transport businesses in Indonesia, Hong Kong, Macau, Other Southeast Asia, Vietnam, Mainland China, and Rest of the world. It is also involved in providing automotive, financial, transport, and information technology services; heavy equipment distribution, mining contracting and operations; developing, owning, and managing premium and ultra-premium mixed-... [Read more]
Analyst Summary
According to 10 analysts, the average rating for J36 stock is "Strong Buy." The 12-month stock price target is $85.12, which is an increase of 52.87% from the latest price.
News
DFI Retail sells stake in Maxim’s in return for Starbucks business, US$340m
Maxim’s Caterers has struck a deal to buy back its shares from DFI Retail Group for US$340 million plus control of its licensed Starbucks business, according to an exchange filing released on Wednesda...
Jardine Matheson removed from APAC Conviction List at Goldman Sachs
Goldman Sachs analysts removed Jardine Matheson (JMHLY) from the firm’s APAC Conviction List as part of its monthly update.
Jardine Matheson Holdings Earnings Call Transcript: H1 2026
Strong H1 2026 performance with 9% adjusted profit growth, robust cash flow, and increased dividends. Portfolio simplification, capital recycling, and the I-MED acquisition support long-term TSR goals, while guidance remains cautious due to Indonesia's uncertainty.
Jardine Matheson Holdings Earnings release: H1 2026
Jardine Matheson Holdings released its H1 2026 earnings on July 30, 2026, summarizing the period's financial results.
Jardine Matheson Holdings Slides: H1 2026
Jardine Matheson Holdings has posted slides in relation to its H1 2026 quarterly earnings report, which was published on July 30, 2026.
Jardine Matheson initiated with a Buy at DBS Bank
DBS Bank initiated coverage of Jardine Matheson (JMHLY) with a Buy rating and $90 price target
Jardine Matheson Holdings Slides: FY 2026
Jardine Matheson Holdings has posted slides in relation to its FY 2026 quarterly earnings report, which was published on June 16, 2026.
Jardine Matheson Holdings Slides: Investor presentation
Jardine Matheson Holdings has posted slides in relation to its latest quarterly earnings report, which was published on June 16, 2026.
Jardine Matheson to acquire 100% interest in I-MED for $2.4B
Jardine Matheson (JMHLY) announces that it has agreed to acquire a 100% interest in I-MED Radiology Network from funds advised by Permira, acting through their UK platform, and other existing…
Jardine Matheson to acquire Australia's I-MED Radiology in $2.4 billion deal
Hong Kong-based conglomerate Jardine Matheson said on Monday that it will acquire Australian medical imaging firm I-MED Radiology Network (I-MED) for an enterprise value of A$3.4 billion ($2.43 bill...
Jardine Matheson initiated with an Overweight at Morgan Stanley
Morgan Stanley initiated coverage of Jardine Matheson (JMHLY) with an Overweight rating and $90 price target The market is assigning negative value to Jardine’s private businesses, implying a stub val...
Jardine Matheson CEO says diversification greatly limits impact of Middle East conflict
Lincoln Pan, CEO of Jardine Matheson, outlines the reasons the Hong Kong-based conglomerate is largely insulated from the negative impact of the Middle East conflict, citing its diversified business m...
Jardine Matheson Holdings Earnings Call Transcript: H2 2025
Strong 2025 results with 11% underlying net profit growth, $4.8B capital recycled, and five-year TSR up to 8.8%. Dividend per share increased to $2.35, and the parent company moved to a net cash position, supporting future investments.
Jardine Matheson Holdings Earnings release: H2 2025
Jardine Matheson Holdings released its H2 2025 earnings on March 10, 2026, summarizing the period's financial results.
Jardine Matheson Holdings Slides: H2 2025
Jardine Matheson Holdings has posted slides in relation to its H2 2025 quarterly earnings report, which was published on March 10, 2026.
Jardine Matheson Holdings Annual report: H2 2025
Jardine Matheson Holdings has published its H2 2025 annual report on March 10, 2026.
Jardine Matheson added to APAC Conviction List at Goldman Sachs
Goldman Sachs analysts added Jardine Matheson (JMHLY) to the firm’s APAC Conviction List as part of its monthly update. The firm expects efficiency gains at Jardine’s portfolio companies to drive…
Jardine Matheson Holdings Earnings Call Transcript: H1 2025
Underlying net profit rose 45% to $798 million, with strong performances across most portfolio companies and significant progress in portfolio simplification and capital recycling. Full-year results are expected to be in line with last year, with a focus on deleveraging and strategic reviews continuing.
Jardine Matheson Holdings Earnings release: H1 2025
Jardine Matheson Holdings released its H1 2025 earnings on July 30, 2025, summarizing the period's financial results.
Jardine Matheson Holdings Slides: H1 2025
Jardine Matheson Holdings has posted slides in relation to its H1 2025 quarterly earnings report, which was published on July 30, 2025.
Jardine Matheson upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs upgraded Jardine Matheson (JMHLY) to Buy from Neutral with a price target of $66.30, up from $47.80. The firm sees upside to consensus earnings estimates from improvement in…
Jardine Matheson upgraded to Overweight from Neutral at JPMorgan
JPMorgan upgraded Jardine Matheson (JMHLY) to Overweight from Neutral with a price target of $57, up from $44. The firm sees a return to earnings growth and potential upside surprises…
Jardine Matheson downgraded to Neutral from Outperform at Macquarie
Macquarie downgraded Jardine Matheson (JMHLY) to Neutral from Outperform with a price target of $46.20, up from $44. The firm lowered its “clean EPS” estimates by 7% and 12%, respectively,…
Jardine Matheson Holdings Earnings Call Transcript: H2 2024
Sharpened investment focus and portfolio simplification drove resilient 2024 results, with underlying profit down 11% due to property impairments but stable core business performance. Capital allocation prioritizes organic growth, balance sheet strength, and selective M&A, with stable 2025 outlook.
Jardine Matheson Holdings Earnings release: H2 2024
Jardine Matheson Holdings released its H2 2024 earnings on March 10, 2025, summarizing the period's financial results.